Evidence
Am J Intellect Dev Disabil. 2024 Jan 1;129(1):1-9. doi: 10.1352/1944-7558-129.1.1.
ABSTRACT
People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition.
PMID:38147886 | DOI:10.1352/1944-7558-129.1.1
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Psychotropic Medication and Psychosocial Service Use Among Transition Age Youth With Autism Spectrum Disorder
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Evidence Blueprint
Psychotropic Medication and Psychosocial Service Use Among Transition Age Youth With Autism Spectrum Disorder
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Psychotropic Medication and Psychosocial Service Use Among Transition Age Youth With Autism Spectrum Disorder
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
